78 related articles for article (PubMed ID: 2140863)
21. Alteration of retinol-binding-protein concentrations by the synthetic retinoid fenretinide in healthy human subjects.
Dimitrov NV; Meyer CJ; Perloff M; Ruppenthal MM; Phillipich MJ; Gilliland D; Malone W; Minn FL
Am J Clin Nutr; 1990 Jun; 51(6):1082-7. PubMed ID: 2140925
[TBL] [Abstract][Full Text] [Related]
22. Progress in applied chemoprevention research.
Kelloff GJ; Malone WF; Boone CW; Sigman CC; Fay JR
Semin Oncol; 1990 Aug; 17(4):438-55. PubMed ID: 2143601
[No Abstract] [Full Text] [Related]
23. Long-term survival of adult mouse mammary glands in culture and their response to a retinoid.
Telang NT; Sarkar NH
Cancer Res; 1983 Oct; 43(10):4891-900. PubMed ID: 6224553
[No Abstract] [Full Text] [Related]
24. Relationship among pharmacokinetics and pharmacodynamics of fenretinide and plasma retinol reduction in neuroblastoma patients.
Formelli F; Cavadini E; Luksch R; Garaventa A; Appierto V; Persiani S
Cancer Chemother Pharmacol; 2010 Oct; 66(5):993-8. PubMed ID: 20532509
[TBL] [Abstract][Full Text] [Related]
25. Reversible nyctalopia and retinopathy in a patient with metastatic cancer treated with anti-heat shock protein 90 therapy.
Munk MR; Fernandes J; Mets M; Patel JD; Johnson ML; Jampol LM
JAMA Ophthalmol; 2014 Jul; 132(7):899-901. PubMed ID: 25010175
[No Abstract] [Full Text] [Related]
26. Pilot trial of the safety, tolerability, and retinoid levels of N-(4-hydroxyphenyl) retinamide in combination with tamoxifen in patients at high risk for developing invasive breast cancer.
Conley B; O'Shaughnessy J; Prindiville S; Lawrence J; Chow C; Jones E; Merino MJ; Kaiser-Kupfer MI; Caruso RC; Podgor M; Goldspiel B; Venzon D; Danforth D; Wu S; Noone M; Goldstein J; Cowan KH; Zujewski J
J Clin Oncol; 2000 Jan; 18(2):275-83. PubMed ID: 10637240
[TBL] [Abstract][Full Text] [Related]
27. Breast tissue accumulation of retinamides in a randomized short-term study of fenretinide.
Sabichi AL; Modiano MR; Lee JJ; Peng YM; Xu MJ; Villar H; Dalton WS; Lippman SM
Clin Cancer Res; 2003 Jul; 9(7):2400-5. PubMed ID: 12855611
[TBL] [Abstract][Full Text] [Related]
28. Prevention of primary prostate cancer in Lobund-Wistar rats by N-(4-hydroxyphenyl)retinamide.
Pollard M; Luckert PH; Sporn MB
Cancer Res; 1991 Jul; 51(13):3610-1. PubMed ID: 1829024
[TBL] [Abstract][Full Text] [Related]
29. Re: Lanvers C et al. Pharmacology of all-trans-retinoic acid in children with acute promyelocytic leukemia. Med Pediatr Oncol 2003;40:293-301.
Formelli F
Pediatr Blood Cancer; 2004 Apr; 42(4):392-3. PubMed ID: 14966841
[No Abstract] [Full Text] [Related]
30. Isotretinoin and night blindness.
Teo K; Yazdabadi A
Australas J Dermatol; 2014 Aug; 55(3):222-4. PubMed ID: 25117163
[TBL] [Abstract][Full Text] [Related]
31. Effect of 4-hydroxyphenylretinamide and retinoic acid on proliferation and cell cycle of cultured human breast cancer cells.
Marth C; Böck G; Daxenbichler G
J Natl Cancer Inst; 1985 Nov; 75(5):871-5. PubMed ID: 2932587
[TBL] [Abstract][Full Text] [Related]
32. Chemoprevention of breast cancer with retinoids.
Veronesi U; De Palo G; Costa A; Formelli F; Marubini E; Del Vecchio M
J Natl Cancer Inst Monogr; 1992; (12):93-7. PubMed ID: 1535505
[TBL] [Abstract][Full Text] [Related]
33. Rhodopsin and visual thresholds in congenital night blindness.
Carr RE; Ripps H; Siegel IM
J Physiol; 1966 Oct; 186(2):103P-104P. PubMed ID: 5298334
[No Abstract] [Full Text] [Related]
34. [Congenital stationary night blindness].
Sui RF; Zhao JL
Zhonghua Yan Ke Za Zhi; 2006 May; 42(5):472-5. PubMed ID: 16762251
[TBL] [Abstract][Full Text] [Related]
35. Analysis of fenretinide and its metabolites in human plasma by liquid chromatography-tandem mass spectrometry and its application to clinical pharmacokinetics.
Cho HE; Min HK
J Pharm Biomed Anal; 2017 Jan; 132():117-124. PubMed ID: 27701038
[TBL] [Abstract][Full Text] [Related]
36. Long-term effects of fenretinide, a retinoic acid derivative, on the insulin-like growth factor system in women with early breast cancer.
Decensi A; Johansson H; Miceli R; Mariani L; Camerini T; Cavadini E; Di Mauro MG; Barreca A; Gonzaga AG; Diani S; Sandri MT; De Palo G; Formelli F
Cancer Epidemiol Biomarkers Prev; 2001 Oct; 10(10):1047-53. PubMed ID: 11588130
[TBL] [Abstract][Full Text] [Related]
37. Possible pathogenesis of congenital stationary night blindness.
Kato M; Aonuma H; Kawamura H; Miura Y; Watanabe I
Jpn J Ophthalmol; 1987; 31(1):88-101. PubMed ID: 3498070
[TBL] [Abstract][Full Text] [Related]
38. Five-year administration of fenretinide: pharmacokinetics and effects on plasma retinol concentrations.
Formelli F; Clerici M; Campa T; Di Mauro MG; Magni A; Mascotti G; Moglia D; De Palo G; Costa A; Veronesi U
J Clin Oncol; 1993 Oct; 11(10):2036-42. PubMed ID: 8410127
[TBL] [Abstract][Full Text] [Related]
39. Retinal and optic evaluation in quinine poisoning.
François J; De Rouck A; Cambie E
Ann Ophthalmol; 1972 Mar; 4(3):177-85. PubMed ID: 4536837
[No Abstract] [Full Text] [Related]
40. [Threshold sensitivity of the monocular, darkness adapted eye with disturbed sense of color].
Denden A
Ber Zusammenkunft Dtsch Ophthalmol Ges; 1966; 67():268-71. PubMed ID: 5299241
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
